Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00747643 · ClinicalTrials.gov registry record · NA

Varenicline Effects on Cue Reactivity and Smoking Reward/Reinforcement

A NA study of Tobacco Dependence, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

Completed
Registry status
NA
Development phase
163
Enrollment target
1
Study location

NCT00747643 is a NA study of Tobacco Dependence that has completed, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 163 participants, below the 473-participant average among 28 other Tobacco Dependence trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00747643, a NA study of Tobacco Dependence, has completed, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

COMPLETED
Registry status
NA
Development phase
163 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study was to find out how varenicline works to help people quit smoking. Varenicline, also known as Chantix™, is an U.S. Food and Drug Administration (FDA) approved medication that has been shown to help people quit smoking. This study was trying to evaluate whether varenicline would change the response to smoking and the desire for cigarettes when compared to an inactive placebo control. This was not a quit smoking treatment study, and participants were not asked or required to stop smoking while in this study.

Conditions Studied

Tobacco Dependence

Interventions

  • DRUG placebo
  • DRUG varenicline

Study Locations (1)

Florida

  • H. Lee Moffitt Cancer Center and Research Institute - Tampa

Trial Details

FieldValue
Enrollment Target 163 participants
Start Date 2008-09
Est. Completion 2010-08
Phase NA

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

502 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00747643

The ClinicalTrials.gov registry entry for NCT00747643 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 163 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 473-participant average among 28 other Tobacco Dependence trials with a reported enrollment target (66% lower). The listed sponsor is H. Lee Moffitt Cancer Center and Research Institute, which has 502 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Tobacco Dependence appearing as the primary indexed condition, and to 2 interventions - of which placebo is the first listed.

NCT00747643 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT00747643 about?

NCT00747643 is a clinical study titled "Varenicline Effects on Cue Reactivity and Smoking Reward/Reinforcement". The purpose of this study was to find out how varenicline works to help people quit smoking. Varenicline, also known as Chantix™, is an U.S. Food and Drug Administration (FDA) approved medication that has been shown to help people quit smoking. This study was trying to evaluate whether varenicline w...

What is the current status of trial NCT00747643?

This trial is currently completed. It is a NA study. The enrollment target is 163 participants. The study started on 2008-09. Estimated completion is 2010-08.

What conditions does trial NCT00747643 study?

This clinical trial studies the following conditions: Tobacco Dependence.

What interventions are being tested in trial NCT00747643?

The interventions under investigation include: placebo (DRUG), varenicline (DRUG).

Who is sponsoring clinical trial NCT00747643?

This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00747643 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Tobacco Dependence

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Tobacco Dependence

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.